17571 VON KARMAN AVENUE, IRVINE, CA
Director Departure - David Moatazedi Not Standing for Re-Election
Biomerica, Inc. Enters $2.23 Million Private Placement Agreement
Biomerica, Inc. Enters $500,000 Securities Purchase Agreement with Buyers
Biomerica, Inc. Elects Directors at 2025 Annual Meeting of Stockholders
Gary Huff, Former CEO, Appointed to Board of Directors
Appoints Eric B. Chin to Board of Directors and Audit Committee Chair
Announces Reverse Stock Split
Shareholder votes
Q1
Year ended May 31, 2026 amended
FY 2025
Q3
Q2
Amended Annual Report
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
Initial Statement of Beneficial Ownership
Schedule 13D - Ownership Report
Statement of Changes in Beneficial Ownership
Submission Upload
Correspondence